Viewing Study NCT06541860


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-03-13 @ 2:35 PM
Study NCT ID: NCT06541860
Status: RECRUITING
Last Update Posted: 2024-08-07
First Post: 2024-04-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DAratumumab and REvlimid REfractory MM
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module